BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27228644)

  • 1. Sex Differences in the Treatment of Psoriatic Arthritis: A Systematic Literature Review.
    Generali E; Sciré CA; Cantarini L; Selmi C
    Isr Med Assoc J; 2016; 18(3-4):203-8. PubMed ID: 27228644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study.
    Zhu B; Edson-Heredia E; Gatz JL; Guo J; Shuler CL
    Clin Ther; 2013 Sep; 35(9):1376-85. PubMed ID: 23954091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.
    Caso F; Cantarini L; Morisco F; Del Puente A; Ramonda R; Fiocco U; Lubrano E; Peluso R; Caso P; Galeazzi M; Punzi L; Scarpa R; Costa L
    Expert Opin Biol Ther; 2015 May; 15(5):641-50. PubMed ID: 25652590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France.
    Soubrier M; Pereira B; Frayssac T; Abdi D; Couderc M; Daron C; Malochet-Guinamand S; Mathieu S; Tatar Z; Tournadre A; Dubost JJ
    Clin Exp Rheumatol; 2016; 34(6):1059-1064. PubMed ID: 27607233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriatic arthritis treatment and the risk of herpes zoster.
    Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
    Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.
    Ash Z; Gaujoux-Viala C; Gossec L; Hensor EM; FitzGerald O; Winthrop K; van der Heijde D; Emery P; Smolen JS; Marzo-Ortega H
    Ann Rheum Dis; 2012 Mar; 71(3):319-26. PubMed ID: 21803753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review.
    López-González R; León L; Loza E; Redondo M; Garcia de Yébenes MJ; Carmona L
    Clin Exp Rheumatol; 2015; 33(4):559-69. PubMed ID: 25602291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors.
    Finzel S; Kraus S; Schmidt S; Hueber A; Rech J; Engelke K; Englbrecht M; Schett G
    Ann Rheum Dis; 2013 Jul; 72(7):1176-81. PubMed ID: 22915620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and drug survival of TNF-inhibitors in the treatment of psoriatic arthritis: A prospective cohort study.
    Aaltonen K; Heinonen A; Joensuu J; Parmanne P; Karjalainen A; Varjolahti-Lehtinen T; Uutela T; Puurtinen-Vilkki M; Arstila L; Blom M; Sokka T; Nordström D
    Semin Arthritis Rheum; 2017 Jun; 46(6):732-739. PubMed ID: 28010883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching biologics in the treatment of psoriatic arthritis.
    Merola JF; Lockshin B; Mody EA
    Semin Arthritis Rheum; 2017 Aug; 47(1):29-37. PubMed ID: 28363434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.
    Iannone F; Lopriore S; Bucci R; Scioscia C; Anelli MG; Notarnicola A; Lapadula G
    Scand J Rheumatol; 2015 May; 44(3):192-9. PubMed ID: 25564882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations.
    da Silva MRR; Dos Santos JBR; Almeida AM; Guerra Júnior AA; Alvares Teodoro J; Acurcio FA
    Expert Rev Clin Immunol; 2019 Aug; 15(8):879-887. PubMed ID: 31192746
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
    Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.
    Elyoussfi S; Thomas BJ; Ciurtin C
    Rheumatol Int; 2016 May; 36(5):603-12. PubMed ID: 26892034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of anti-TNF switching in psoriatic arthritis: a systematic review of the literature.
    Reddy SM; Crean S; Martin AL; Burns MD; Palmer JB
    Clin Rheumatol; 2016 Dec; 35(12):2955-2966. PubMed ID: 27730309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Clin Rheumatol; 2016 Jul; 35(7):1795-803. PubMed ID: 26852316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.
    Saad AA; Symmons DP; Noyce PR; Ashcroft DM
    J Rheumatol; 2008 May; 35(5):883-90. PubMed ID: 18381787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission.
    Araujo EG; Finzel S; Englbrecht M; Schreiber DA; Faustini F; Hueber A; Nas K; Rech J; Schett G
    Ann Rheum Dis; 2015 Apr; 74(4):655-60. PubMed ID: 24336010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.